<DOC>
	<DOCNO>NCT00772057</DOCNO>
	<brief_summary>Background Aims : The efficacy portal pressure reduction beta blocker management small ( ≤5 mm ) esophageal varix patient cirrhosis clear . The present randomized control trial aim address issue . The investigator also assess utility serial HVPG measurements patient . Patients Methods : Consecutive patient cirrhosis small varix , history variceal bleed , randomize receive propranolol placebo . These patient randomize undergo HVPG , baseline HVPG , serial HVPG measurement . Propranolol titrate reduce heart-rate 55/min .</brief_summary>
	<brief_title>Beta-blockers Prevention Of Growth Of Small Esophageal Varices In Cirrhosis : An Randomized Controlled Trial ( RCT )</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>A clinical , radiological histologic diagnosis cirrhosis make Age 18 70 year Esophageal varix small ( i.e . ≤5 mm grade 1 2 accord Conn et al ) . Presence previous variceal bleed Previous medical , surgical endoscopic treatment portal hypertension ChildPugh score &gt; 13 Neoplastic disease site Splenic portal vein thrombosis Concurrent illnesses expect decrease life expectancy le one year Pregnancy Contraindication betablockers ( atrioventricular block , sinus bradycardia heart rate &lt; 50 beat per minute , arterial hypotension systolic blood pressure &lt; 90 mm Hg , heart failure , asthma , peripheral arterial disease , diabetes need insulin treatment ) Concurrent antiviral treatment study period Inability perform followup Failure give consent participate study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>